Pancreatic

05129 A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas (CA 046)

CALGB 80701 CALGB 80701 Randomized phase II study of everolimus alone versus everolimus plus bevacizumab in patients with locally advanced or metastatic pancreatic neuroendocrine tumors

Please contact the NYOH Research Department for more information on clinical trials at (518) 489-0044 ext. 1239